Home The Action Management Committee Kirsti Ytrehus (NO)

Thu,27Apr2017

Kirsti Ytrehus

Professor Dr.Med.
Head of Cardiovascular Research Group,
Dept. of Medical Biology,
Faculty of Health Sciences,
University of Tromso, Norway
Tel.: office 004777644781 (or mobile 004795106332)
Fax:  004777623200
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Research interests

  • Experimental heart research using rodent models with focus on myocardial ischemia, hypertrophy and failure
  • The role of Xanthine Oxidase and NADPH Oxidase derived reactive oxygen species (ROS) in heart pathophysiology 
  • The interaction between  gaseous transmitters and ROS in the heart
  • Cardio-protection

Selected Recent Publications

  • Johansen D, Ytrehus K, Baxter GF. Hydrogen sulfide protects against myocardial ischemia-reperfusion injury. Basic Res Cardiol 2006, 1: 53-60 (Epub 2005 Nov 21).
  • Sovershaev MA, Egorina EM, Andreasen TV, Jonassen AK, Ytrehus K. Preconditioning by 17beta-estradiol in isolated rat heart depends of PI3K/PKB pathway, PKC and ROS. Am J Physiol 2006, 291(6): H1554-1562.
  • Lund T, Hermansen SE, Andreasen TV, Olsen JO, Østerud B, Myrmel T, Ytrehus K. Shear stress regulates inflammatory and thrombogenic gene transcripts in cultured human endothelial progenitor cells. J Hemostasis Trombosis 2010, 104(3):582-91. Epub 2010 Jul 20
  • Johansen D, Sanden E, Hagve M, Chu X, Sundset R, Ytrehus K Heptanol triggers cardioprotection via mitochondrial mechanisms and mitochondrial potassium channel opening in rat hearts. Acta Physiol 2011, 201(4):435-44. Epub 2010
  • Johansen D, Cruciani V, Sundset R, Ytrehus K, Mikalsen S-O. Ischemia induces closure of gap junction channels and opening of hemichannels in heart-derived cells and tissue. Cell Physiol Biochem 2011, 28:103-114.

ESF

COST

POLICY STATEMENT: Biomedicine and Molecular Biosciences Action BM1005 is funded by COST, through its implementing agent the European Science Foundation.